Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03955939
Title A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BEL

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010-0269 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229-3307 United States Details
Cliniques Universitaires Saint-Luc Brussels 1200 Belgium Details
Universitair Ziekenhuis Antwerpen Edegem 2650 Belgium Details
Universitair Ziekenhuis Gent Gent 9000 Belgium Details
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg Leuven 3000 Belgium Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field